CAMILLE LEDFORD: Open Payments
NPI 1235301946 · HIAWASSEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 15 payments from 10 companies in 2025. Trend: 2023 $397 · 2024 $379 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $55 |
| Novo Nordisk Inc | 3 | $52 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: MOUNJARO, Cologuard Collection Kit, VRAYLAR, EPKINLY, TRINTELLIX, FARXIGA, REPATHA, CAPLYTA.
Industry payments across GA — which companies pay providers there.
